Article

Strategies for Managing Inflammatory Bowel Disease (IBD) Symptoms

When biologics to treat inflammatory bowel disease (IBD) were first released over two decades ago, they greatly improved quality of life for many patients. But these first-generation therapies have their shortcomings. Fewer than half of patients treated with these inflammation-blocking drugs will be in remission after one year of treatment. These treatments can also suppress the immune system, making patients vulnerable to infection.But now, thanks to advancements in our understanding of the...

Real People

Eric Hudson: A Lens on Life

I’m a husband and father. A busy regional business director at Pfizer. An endurance athlete. And very grateful to be here. A few years ago, I was training for an Ironman when my left calf became swollen and tight after a long run. I went to an orthopedic surgeon, who did an ultrasound that showed a deep vein thrombosis in my left thigh. After I was admitted to the hospital, an ultrasound showed a pulmonary embolus in one lung. My life changed in that moment. Now I am managing my condition and...

Real People

Dear Scientist: NASH - Meet Ann-Marie

As a bridge between patients and scientists, our own Ann-Marie Richard connects with patients like Jenni Tucker – who was diagnosed with nonalcoholic steatohepatitis at age 19 – to learn about their experiences with NASH, insights that can help guide research toward patients’ needs.

Science & Innovation

Behind the Breakthroughs: The Scientists Behind Pfizer’s Cancer Research

Have you ever wondered what makes a cancer researcher tick, or how the pursuit of life-changing treatments became their life’s work? How about what keeps them up at night, and what goes through their mind when an experiment fails? And what about the things that inspire and motivate them every day in the lab? Click on the videos below to find out, and to get to know the talented scientists at Pfizer who are working to deliver the next wave of cancer breakthroughs.   Meet Our Scientists

The Rise of RNA: The Cellular Workhorse Behind a New Class of Next-Gen Therapies

In a new Get Science series, we’re exploring how recent insights into RNA’s role in a variety of biological processes are helping scientists develop promising scientific breathroughs that may lead to new medicines for diseases, such as cancer and autoimmune conditions. A workhorse in the factory Among RNA’s most important roles is the transcription and delivery of genetic instructions from the nucleus to the cytoplasm where proteins are made. RNA also has catalytic, structural and regulatory...

Living & Wellbeing

Using ‘Omics to Understand the Rise in Breast Cancers Among Young Asians

By Get Science Staff - This article originally published on Get Science Asian women, compared to their counterparts in western countries, are diagnosed with breast cancer at earlier ages and face a worse prognosis. In an effort to better understand this patient population, scientists from Pfizer and Samsung Medical Center (SMC) in Seoul, Korea, have embarked on a multi-phase project to do multi-omic profiling of the tumors of some 187 younger Korean breast cancer patients. Multi-omics refers...

Science & Innovation

Attacking Cancer Cells That Develop Resistance

By Get Science Staff - This article originally published on Get Science When cancer patients receive therapy for an extended time, they often face the specter of drug resistance as tumor cells mutate and find ways to evade the cancer-killing medicines. Exploring new ways to disarm rogue cells that have developed resistance is a major field of modern cancer research. One way to address the issue of resistance is to attack cancer through the fundamental processes that drive their core mission —...

Purpose & Ideals

Steps to a Stronger Doctor-Patient Relationship

ul.custom-margin { margin-top: 15px; } We’re dedicated to sharing the perspectives of people affected by chronic inflammatory conditions like rheumatoid arthritis (RA). That’s why we created Arthritis.com, a place where people living with RA can find inspiration, lifestyle advice, tools and disease information. Following is an article from Arthritis.com contributor and editorial board member Ara Dikranian, M.D. Dr. Dikranian was compensated by Pfizer to share his perspective as a...

Living & Wellbeing

Four Things to Know About Managing Your Rheumatoid Arthritis with Your Doctor

We’re dedicated to sharing the perspectives of people affected by chronic inflammatory conditions like rheumatoid arthritis (RA). That’s why we created Arthritis.com, a place where people living with RA can find inspiration, lifestyle advice, tools and disease information. Following is an article from Arthritis.com contributor and editorial board member Ara Dikranian, M.D.Managing a chronic condition like rheumatoid arthritis (RA) requires an equal partnership between doctors and patients. Here...

The Table of Everything: A Scientist’s Quest to Make Human Genetic Data More User-Friendly

Since the human genome was first sequenced in 2003, scientists have collected a wealth of genetic information that could potentially be used to help create new medicines. Remarkably, as sequencing technology gets faster and cheaper, the amount of human genetic data now doubles every seven months. But in order to keep pace with the rapid generation of genetic information and to make use of it in drug discovery, this information needs to be made more accessible for scientists of all stripes, not...

Partnering to Turn the 'Undruggable' into Promising Targets

In the world of drug discovery, “undruggable” targets are like the stubborn children of biology, proteins that are considered too challenging to bind with conventional molecules. With the rapid pace of scientific advancement, however, the “undruggable” targets of yesterday now represent a promising new area of research. Such is the case with deubiquitinating enzymes (DUBs), a family of some 100 proteins that play a role in regulating the right balance of proteins in cells. In 2017, academic...

Living & Wellbeing

Three Things to Know About Venous Thromboembolism and Cancer

Venous thromboembolism (VTE) can be a dangerous, potentially deadly medical condition that is a leading cause of death and disability worldwide and the third most common cause of vascular death after heart attack and stroke.1 VTE encompasses two serious conditions: deep vein thrombosis (DVT), a blood clot in a deep vein, and pulmonary embolism (PE), a potentially life-threatening condition in which a blood clot blocks a blood vessel in the lungs. Despite the potential dangers of this condition...